You are here: Home: Meet The Professors Colorectal Vol. 1 Issue 1: Faculty Affiliations and Disclosures

Faculty Affiliations

	Steven A Curley, MD Professor of Surgical Oncology Chief, Gastrointestinal Tumor Surgery The University of Texas MD Anderson Cancer Center Houston, Texas		Daniel G Haller, MD Professor of Medicine Abramson Cancer Center at the University of Pennsylvania Philadelphia, Pennsylvania
	Charles S Fuchs, MD, MPH Associate Professor of Medicine Dana-Farber Cancer Institute Harvard University Boston, Massachusetts		Neal J Meropol, MD Director, Gastrointestinal Cancer Program Director, Gastrointestinal Tumor Risk Assessment Program Divisions of Medical Science and Population Science Fox Chase Cancer Center Philadelphia, Pennsylvania

Medical Oncologist Community Panel

Roman A Gastesi, MD Ft Lauderdale, Florida Philip Glynn, MD Springfield, Massachusetts Stephen A Grabelsky, MD Boca Raton, Florida Lowell L Hart, MD, FACP Fort Myers, Florida

William N Harwin, MD Fort Myers, Florida Atif M Hussein, MD Hollywood, Florida Sobha Kurian, MD Morgantown, West Virginia William G Reeves, MD Youngstown, Ohio

Brenda L Towell, MD Austin, Texas Jeffrey L Vacirca, MD East Setauket, New York Paul L Weinstein, MD Stamford, Connecticut

CONTENT VALIDATION AND DISCLOSURES

Research To Practice is committed to providing its participants with high-quality, unbiased and state-of-the-art education. We assess potential conflicts of interest with faculty, planners and managers of CME activities. Real or apparent conflicts of interest are identified and resolved by a peer review content validation process. The content of each activity is reviewed by both a member of the scientific staff and an external independent reviewer for fair balance, scientific objectivity of studies referenced and patient care recommendations.

The scientific staff and consultants for Research To Practice are involved in the development and review of content for educational activities and report the following real or apparent conflicts of interest for themselves (or their spouses/partners) that have been resolved through a peer review process: Richard Kaderman, PhD, Neil Love, MD, Douglas Paley, Margaret Peng, Lilliam Sklaver Poltorack, PharmD, Ginelle Suarez, Chris Thomson, MD, MS, Erin Wall and Kathryn Ault Ziel, PhD — no real or apparent conflicts of interest to report; Sally Bogert, RNC, WHCNP — shareholder of Amgen Inc and Genentech Inc. Research To Practice receives education grants from Abraxis Oncology, Amgen Inc, AstraZeneca Pharmaceuticals LP, Bayer Pharmaceuticals Corporation/Onyx Pharmaceuticals Inc, Genentech Inc/OSI Pharmaceuticals Inc, Genomic Health Inc, Roche Laboratories Inc and Sanofi-Aventis, who have no influence on the content development of our educational activities.

In addition, the following faculty (and their spouses/partners) have reported real or apparent conflicts of interest that have been resolved through a peer review process:

Dr Curley — Consulting Fees: Genentech Inc, Sanofi-Aventis. Dr Fuchs — Honoraria: Genentech Inc, Pfizer Inc, Sanofi-Aventis. Dr Haller — Consulting Fees: Genentech Inc, Roche Laboratories Inc, Sanofi-Aventis; Contracted Research: Bristol-Myers Squibb Company, Roche Laboratories Inc, Sanofi-Aventis. Dr Meropol — Consulting Fees: Amgen Inc, Genentech Inc, Pfizer Inc.

This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration. Research To Practice does not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. The opinions expressed are those of the presenters and are not to be construed as those of the publisher or grantors.